Back to top
Read MoreHide Full Article

·         Shares of Expedia Inc. (EXPE - Free Report) declined 4.5% after the company’s Chief Executive Officer Dara Khosrowshahi announced that he would be joining Uber as CEO

·         Biogen Inc.’s (BIIB - Free Report) shares surged 2.5% following positive results from an Alzhiemer’s drug study

·         Shares of Gilead Sciences Inc. (GILD - Free Report) increased 1.2% after it entered into an agreement with Kite Pharma Inc. to acquire the company for a whopping $11 billion in cash

·         Johnson & Johnson’s (JNJ - Free Report) shares increased almost 0.1% after it announced favorable results in a phase 3 study of its blood-thinning drug Xarelto




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Expedia, Inc. (EXPE) - free report >>

Johnson & Johnson (JNJ) - free report >>

Gilead Sciences, Inc. (GILD) - free report >>

Biogen Inc. (BIIB) - free report >>


More from Zacks Corporate Summary

You May Like